Skip to content

Teriparatide (PTH 1-34) studies: 484 papers with results

Page 9 of 10

  1. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.

    Takano Y · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1996

    Animal study (in vivo) · rat · 5 results

  2. Parathyroid hormone (1-34) ameliorates cartilage degeneration and subchondral bone deterioration in collagenase-induced osteoarthritis model in mice.

    Shao LT · Bone & joint research · 2020

    Animal study (in vivo) · mouse · 13 results

  3. Parathyroid hormone PTH(1-34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits.

    Aleksyniene R · Acta orthopaedica · 2009

    Animal study (in vivo) · new zealand white rabbits · 8 results

  4. Intermittently administered parathyroid hormone 1-34 reverses bone loss and structural impairment in orchiectomized adult rats.

    Gabet Y · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2005

    Animal study (in vivo) · rat · 7 results

  5. Effects of abaloparatide and teriparatide on bone resorption and bone formation in female mice.

    Arlt H · Bone reports · 2020

    Animal study (in vivo) · mouse · 24 results

  6. Endogenous PTH deficiency impairs fracture healing and impedes the fracture-healing efficacy of exogenous PTH(1-34).

    Ren Y · PloS one · 2011

    Animal study (in vivo) · mouse · 14 results

  7. Longitudinal Changes of Circulating miRNAs During Bisphosphonate and Teriparatide Treatment in an Animal Model of Postmenopausal Osteoporosis.

    Weigl M · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2021

    Animal study (in vivo) · sprague dawley rats · 14 results

  8. Teriparatide Improves Bone and Lipid Metabolism in a Male Rat Model of Type 2 Diabetes Mellitus.

    Nomura S · Endocrinology · 2019

    Animal study (in vivo) · rat · 13 results

  9. Anabolic effect of intermittent PTH(1-34) on the local microenvironment during the late phase of periodontal repair in a rat model of tooth root resorption.

    Lossdörfer S · Clinical oral investigations · 2010

    Animal study (in vivo) · rat · 1 result

  10. Parathyroid hormone(1-34) exhibits more comprehensive effects than celecoxib in cartilage metabolism and maintaining subchondral bone micro-architecture in meniscectomized guinea pigs.

    Dai MW · Osteoarthritis and cartilage · 2016

    Animal study (in vivo) · guinea pig · 13 results

  11. Combined effects of systemic parathyroid hormone (1-34) and locally delivered neutral self-assembling peptide hydrogel in the treatment of periodontal defects: An experimental in vivo investigation.

    Yoshida W · Journal of clinical periodontology · 2019

    Animal study (in vivo) · rat · 8 results

  12. Effect of teriparatide on repair of femoral metaphyseal defect in ovariectomized rats.

    Tao ZS · Zeitschrift fur Gerontologie und Geriatrie · 2016

    Animal study (in vivo) · rat · 6 results

  13. Histopathological Effects of Teriparatide in Medication-Related Osteonecrosis of the Jaw: An Animal Study.

    Keskinruzgar A · Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons · 2016

    Animal study (in vivo) · rat · 5 results

  14. PTH(1-34) Treatment Increases Bisphosphonate Turnover in Fracture Repair in Rats.

    Murphy CM · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2015

    Animal study (in vivo) · rat · 6 results

  15. Examining the influence of PTH(1-34) on tissue strength and composition.

    Gardinier JD · Bone · 2018

    Animal study (in vivo) · c57bl and 6j mice · 7 results

  16. Role of Teriparatide in Glucocorticoid-induced Osteoporosis through Regulating Cellular Reactive Oxygen Species.

    Wang T · Orthopaedic surgery · 2018

    Animal study (in vivo) · 10 results

  17. Prevention of atrophic nonunion by the systemic administration of parathyroid hormone (PTH 1-34) in an experimental animal model.

    Lin EA · Journal of orthopaedic trauma · 2012

    Animal study (in vivo) · mouse · 3 results

  18. Frequent administration of abaloparatide shows greater gains in bone anabolic window and bone mineral density in mice: A comparison with teriparatide.

    Makino A · Bone · 2021

    Animal study (in vivo) · mouse · 16 results

  19. Single-dose local administration of teriparatide with a octacalcium phosphate collagen composite enhances bone regeneration in a rodent critical-sized calvarial defect.

    Kajii F · Journal of biomedical materials research. Part B, Applied biomaterials · 2018

    Animal study (in vivo) · rodent · 5 results

  20. Individual and combining effects of anti-RANKL monoclonal antibody and teriparatide in ovariectomized mice.

    Tokuyama N · Bone reports · 2015

    Animal study (in vivo) · mouse · 6 results

  21. Teriparatide improves alveolar bone modelling after tooth extraction in orchiectomized rats.

    de Oliveira Puttini I · Archives of oral biology · 2019

    Animal study (in vivo) · rat · 9 results

  22. Parathyroid hormone 1-34 enhances extracellular matrix deposition and organization during flexor tendon repair.

    Lee DJ · Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2015

    Animal study (in vivo) · mouse · 9 results

  23. Vitamin K-dependent carboxylation of osteocalcin affects the efficacy of teriparatide (PTH(1-34)) for skeletal repair.

    Shimizu T · Bone · 2014

    Animal study (in vivo) · rat · 5 results

  24. Anabolic effects of recombinant human parathyroid hormone (1 - 84) and synthetic human parathyroid hormone (1 - 34) on the mandibles of osteopenic ovariectomized rats with maxillary molar extraction.

    Kawane T · Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2002

    Animal study (in vivo) · rat · 17 results

  25. Abaloparatide outperforms teriparatide in protecting against alveolar bone loss in experimental periodontitis.

    Li Y · Journal of periodontology · 2023

    Animal study (in vivo) · rat · 14 results

  26. Comparative study in estrogen-depleted mice identifies skeletal and osteocyte transcriptomic responses to abaloparatide and teriparatide.

    Lv Z · JCI insight · 2023

    Animal study (in vivo) · mouse · 9 results

  27. Abaloparatide is more potent than teriparatide in restoring bone mass and strength in type 1 diabetic male mice.

    Marino S · Bone · 2024

    Animal study (in vivo) · mouse · 23 results

  28. Abaloparatide and teriparatide enhance mandibular growth in adolescent rats with site-specific and mechano-related effects.

    Wang R · European journal of orthodontics · 2023

    Animal study (in vivo) · rat · 34 results

  29. Mechanisms of vasodilation to PTH 1-84, PTH 1-34, and PTHrP 1-34 in rat bone resistance arteries.

    Benson T · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2016

    Ex vivo tissue · rat · 6 results

  30. Sustained release of PTH(1-34) from PLGA microspheres suppresses osteoarthritis progression in rats.

    Eswaramoorthy R · Acta biomaterialia · 2012

    In vitro (cells) · 6 results

  31. Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.

    Leder BZ · Lancet (London, England) · 2015

    Not a test of Teriparatide (PTH 1-34) alone · 18 results

  32. Effects of teriparatide in postmenopausal women with osteoporosis on prior alendronate or raloxifene: differences between stopping and continuing the antiresorptive agent.

    Cosman F · The Journal of clinical endocrinology and metabolism · 2009

    Not a test of Teriparatide (PTH 1-34) alone · 14 results

  33. Standard Versus Cyclic Teriparatide and Denosumab Treatment for Osteoporosis: A Randomized Trial.

    Cosman F · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2020

    Not a test of Teriparatide (PTH 1-34) alone · 11 results

  34. Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism.

    Winer KK · The Journal of pediatrics · 2014

    Not a test of Teriparatide (PTH 1-34) alone · 9 results

  35. Safety and efficacy of Wharton's jelly-derived mesenchymal stem cells with teriparatide for osteoporotic vertebral fractures: A phase I/IIa study.

    Shim J · Stem cells translational medicine · 2021

    Not a test of Teriparatide (PTH 1-34) alone · 9 results

  36. Skeletal unloading alleviates the anabolic action of intermittent PTH(1-34) in mouse tibia in association with inhibition of PTH-induced increase in c-fos mRNA in bone marrow cells.

    Tanaka S · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2004

    Not a test of Teriparatide (PTH 1-34) alone · 9 results

  37. Denosumab After Teriparatide in Premenopausal Women With Idiopathic Osteoporosis.

    Shane E · The Journal of clinical endocrinology and metabolism · 2022

    Not a test of Teriparatide (PTH 1-34) alone · 9 results

  38. Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis.

    Chen P · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2005

    Not a test of Teriparatide (PTH 1-34) alone · 8 results

  39. An injectable liposome-anchored teriparatide incorporated gallic acid-grafted gelatin hydrogel for osteoarthritis treatment.

    Li G · Nature communications · 2023

    Not a test of Teriparatide (PTH 1-34) alone · 8 results

  40. The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1-34)].

    Kurland ES · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2004

    Not a test of Teriparatide (PTH 1-34) alone · 8 results

  41. Relationship between bone turnover and density with teriparatide, denosumab or both in women in the DATA study.

    Tsai JN · Bone · 2017

    Not a test of Teriparatide (PTH 1-34) alone · 8 results

  42. An effect comparison of teriparatide and bisphosphonate on posterior lumbar interbody fusion in patients with osteoporosis: a prospective cohort study and preliminary data.

    Cho PG · European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society · 2017

    Not a test of Teriparatide (PTH 1-34) alone · 6 results

  43. The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis.

    Liu H · Archives of internal medicine · 2006

    Not a test of Teriparatide (PTH 1-34) alone · 6 results

  44. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures.

    Choe EY · Journal of bone and mineral metabolism · 2012

    Not a test of Teriparatide (PTH 1-34) alone · 6 results

  45. Biomechanical effects of teriparatide in women with osteoporosis treated previously with alendronate and risedronate: results from quantitative computed tomography-based finite element analysis of the vertebral body.

    Chevalier Y · Bone · 2010

    Not a test of Teriparatide (PTH 1-34) alone · 6 results

  46. The Effect of Zoledronic Acid on Bone Microarchitecture and Strength after Denosumab and Teriparatide Administration: DATA-HD Study Extension.

    Ramchand SK · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2023

    Not a test of Teriparatide (PTH 1-34) alone · 6 results

  47. Biosimilarity Assessment of the Biosimilar Teriparatide Candidate and the Reference Drug in Healthy Subjects.

    Wang X · Clinical pharmacology in drug development · 2023

    Not a test of Teriparatide (PTH 1-34) alone · 6 results

  48. Comparison of Efficacy of Teriparatide (Parathyroid Hormone 1-34) Alone and in Combination with Zoledronic Acid for Osteoporosis in Postmenopausal Women.

    Wei K · Journal of the College of Physicians and Surgeons--Pakistan : JCPSP · 2021

    Not a test of Teriparatide (PTH 1-34) alone · 6 results

  49. Characterizing patients initiating abaloparatide, teriparatide, or denosumab in a real-world setting: a US linked claims and EMR database analysis.

    Imel EA · Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2020

    Not a test of Teriparatide (PTH 1-34) alone · 13 results

  50. Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D.

    Slovik DM · Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 1986

    Not a test of Teriparatide (PTH 1-34) alone · 5 results

How PepBank reports evidence